{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-006578","form_type":"8-K","ticker":"BIIB","cik":"0000875045","company_name":"BIOGEN INC.","filed_at":"2025-01-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.577166+00:00","generated_at":"2026-05-28T01:34:36.578030+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Biogen appoints Sean Godbout as Chief Accounting Officer effective March 1, 2025","bullets":["Sean Godbout to succeed Robin Kramer as CAO and principal accounting officer; Kramer transitions to CFO role upon McDonnell's retirement.","Michael McDonnell to retire as CFO on March 1, 2025; Kramer previously announced as successor.","Godbout, age 50, internal promotion from Global Corporate Controller (since Oct 2023), joined Biogen in 2007.","Base salary $400,000; annual bonus target 40% of base; eligible for long-term incentive grants and executive severance plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-006578","json":"https://secwatch.observer/filing/0001193125-25-006578.json","markdown":"https://secwatch.observer/filing/0001193125-25-006578.md","text":"https://secwatch.observer/filing/0001193125-25-006578.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875045/000119312525006578/0001193125-25-006578-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875045/000119312525006578/d830064d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T01:34:36.578030+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2463e4e8c9","claim":"Robin Kramer was appointed as Chief Financial Officer at BIOGEN INC..","evidence_excerpt":"As previously announced, Ms. Kramer has been appointed the Company’s Chief Financial Officer, effective upon the retirement of Michael McDonnell, the Company’s current Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/875045/000119312525006578/0001193125-25-006578-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}]},{"claim_id":"65011df29d","claim":"Sean Godbout was appointed as Chief Accounting Officer at BIOGEN INC..","evidence_excerpt":"On January 13, 2025, Biogen Inc. (the “Company”) appointed Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller and designated Mr. Godbout as the Company’s principal accounting officer, in each case effective as of March 1, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/875045/000119312525006578/0001193125-25-006578-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Accounting Officer"}]},{"claim_id":"852ced4184","claim":"Michael McDonnell departed as Chief Financial Officer at BIOGEN INC..","evidence_excerpt":"Mr. McDonnell will retire on March 1, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/875045/000119312525006578/0001193125-25-006578-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Chief Financial Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}